Literature DB >> 23161378

Factors that impact the outcome of endoscopic correction of vesicoureteral reflux: a multivariate analysis.

Abdol-Mohammad Kajbafzadeh1, Ali Tourchi, Zahra Aryan.   

Abstract

PURPOSE: To identify independent factors that may predict vesicoureteral reflux (VUR) resolution after endoscopic treatment using dextranomer/hyaluronic acid copolymer (Deflux) in children free of anatomical anomalies.
MATERIALS AND METHODS: A retrospective study was conducted in our pediatric referral center from 1998 to 2011 on children with primary VUR who underwent endoscopic injection of Deflux with or without concomitant autologous blood injection (called HABIT or HIT, respectively). Children with secondary VUR or incomplete records were excluded from the study. Potential factors were divided into three categories including preoperative, intraoperative and postoperative. Success was defined as no sign of VUR on postoperative voiding cystourethrogram. Univariate and multivariate logistic regression models were constructed to identify independent factors that may predict success. Odds ratio (OR) and 95 % confidence interval (95 % CI) for prediction of success were estimated for each factor.
RESULTS: From 485 children received Deflux injection, a total of 372 with a mean age of 3.10 years (ranged from 6 months to 12 years) were included in the study and endoscopic management was successful in 322 (86.6 %) of them. Of the patients, 185 (49.7 %) underwent HIT and 187 (50.3 %) underwent HABIT technique. On univariate analysis, VUR grade from preoperative category (OR = 4.79, 95 % CI = 2.22-10.30, p = 0.000), operation technique (OR = 0.33, 95 % CI = 0.17-0.64, p = 0.001) and presence of mound on postoperative sonography (OR = 0.06, 95 % CI = 0.02-0.16, p = 0.000) were associated with success. On multivariate analysis, preoperative VUR grade (OR = 4.85, 95 % CI = 2.49-8.96, p = 0.000) and identification of mound on postoperative sonography (OR = 0.07, 95 % CI = 0.01-0.18, p = 0.000) remained as independent success predictors.
CONCLUSION: Based on this study, successful VUR correction after the endoscopic injection of Deflux can be predicted with respect to preoperative VUR grade and presence of mound after operation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23161378     DOI: 10.1007/s11255-012-0327-5

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  30 in total

1.  Multivariate analysis of factors predicting success with dextranomer/hyaluronic acid injection for vesicoureteral reflux.

Authors:  Selcuk Yucel; Amit Gupta; Warren Snodgrass
Journal:  J Urol       Date:  2007-04       Impact factor: 7.450

2.  Predicting success in the endoscopic management of pediatric vesicoureteral reflux.

Authors:  Jonathan C Routh; Yuri Reinberg
Journal:  Urology       Date:  2009-11-22       Impact factor: 2.649

Review 3.  Long-term results of endoscopic treatment of vesicoureteric reflux with different tissue-augmenting substances.

Authors:  Boris Chertin; Stanislav Kocherov
Journal:  J Pediatr Urol       Date:  2009-11-05       Impact factor: 1.830

4.  Intermediate to long-term follow-up indicates low risk of recurrence after Double HIT endoscopic treatment for primary vesico-ureteral reflux.

Authors:  Jonathan F Kalisvaart; Hal C Scherz; Scott Cuda; Jonathan D Kaye; Andrew J Kirsch
Journal:  J Pediatr Urol       Date:  2011-08-04       Impact factor: 1.830

Review 5.  Summary of the AUA Guideline on Management of Primary Vesicoureteral Reflux in Children.

Authors:  Craig A Peters; Steven J Skoog; Billy S Arant; Hillary L Copp; Jack S Elder; R Guy Hudson; Antoine E Khoury; Armando J Lorenzo; Hans G Pohl; Ellen Shapiro; Warren T Snodgrass; Mireya Diaz
Journal:  J Urol       Date:  2010-07-21       Impact factor: 7.450

6.  Salvage dextranomer-hyaluronic acid copolymer for persistent reflux after ureteral reimplantation: early success rates.

Authors:  Yuval Bar-Yosef; Miguel Castellan; Devandra Joshi; Andrew Labbie; Rafael Gosalbez
Journal:  J Urol       Date:  2011-04-28       Impact factor: 7.450

7.  Endoscopic treatment with stabilized nonanimal hyaluronic acid/dextranomer gel is effective in vesicoureteral reflux associated with bladder dysfunction.

Authors:  Göran Läckgren; Erik Sköldenberg; Arne Stenberg
Journal:  J Urol       Date:  2007-03       Impact factor: 7.450

8.  Lack of distant migration after injection of a 125iodine labeled dextranomer based implant into the rabbit bladder.

Authors:  A M Stenberg; A Sundin; B S Larsson; G Läckgren; A Stenberg
Journal:  J Urol       Date:  1997-11       Impact factor: 7.450

9.  Endoscopic injection of dextranomer hyaluronic acid copolymer for the treatment of vesicoureteral reflux in duplex ureters.

Authors:  Joseph A Molitierno; Hal C Scherz; Andrew J Kirsch
Journal:  J Pediatr Urol       Date:  2008-04-09       Impact factor: 1.830

10.  Learning from the learning curve: factors associated with successful endoscopic correction of vesicoureteral reflux using dextranomer/hyaluronic acid copolymer.

Authors:  Sumit Dave; Armando J Lorenzo; Antoine E Khoury; Luis H P Braga; Sean J Skeldon; Mohammed Suoub; Walid Farhat; João L Pippi Salle; Darius J Bägli
Journal:  J Urol       Date:  2008-08-16       Impact factor: 7.450

View more
  3 in total

1.  Is a secondary procedure necessary in every case of failed endoscopic treatment for vesicoureteral reflux?

Authors:  Hyun Jin Jung; Young Jae Im; Yong Seung Lee; Myung Joo Kim; Sang Won Han
Journal:  Korean J Urol       Date:  2015-04-24

2.  Intraoperative contrast-enhanced urosonography during endoscopic treatment of vesicoureteral reflux in children.

Authors:  Magdalena Maria Woźniak; Paweł Osemlak; Agata Pawelec; Agnieszka Brodzisz; Paweł Nachulewicz; Andrzej Paweł Wieczorek; Maria Małgorzata Zajączkowska
Journal:  Pediatr Radiol       Date:  2014-04-10

Review 3.  Endoscopic injection therapy.

Authors:  Sang Woon Kim; Yong Seung Lee; Sang Won Han
Journal:  Investig Clin Urol       Date:  2017-06-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.